| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | Aug 21, 2025 | Liquidia Corp | Director | Sell | 22.5 | -5,000 | -12.90% | ✗ | $135.9K |
| Jun 7, 2024 | Jun 7, 2024 | Kymera Therapeutics, Inc. | Director | Sell | 7.5 | -8,500 | -100.00% | ✓ | $280.4K |
| Dec 29, 2014 | Dec 31, 2014 | Verastem, Inc. | Chief Medical Officer | Buy | 90.0 | +750 | 100.00% | ✗ | $6.5K |